An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease
Latest Information Update: 25 Jul 2022
At a glance
- Drugs Nevirapine (Primary)
- Indications HIV-1 infections
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim
Most Recent Events
- 25 Jul 2022 New trial record